Zoetis (ZTS) Profit After Tax Growth (1y) (2013 - 2026)
Zoetis (ZTS) Profit After Tax Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -303.53% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | -17.27% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 34.32% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.47 Bn | 397.90 Mn | -99.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.82% |
| Mar 31, 2026 | -0.17% |
| Dec 31, 2025 | 3.79% |
| Sep 30, 2025 | 5.72% |
| Jun 30, 2025 | 15.06% |
| Mar 31, 2025 | 0.50% |
| Dec 31, 2024 | 10.25% |
| Sep 30, 2024 | 14.43% |
| Jun 30, 2024 | -7.00% |
| Mar 31, 2024 | 8.71% |
| Dec 31, 2023 | 14.32% |
| Sep 30, 2023 | 12.67% |
| Jun 30, 2023 | 26.84% |
| Mar 31, 2023 | -7.24% |
| Dec 31, 2022 | 12.17% |
| Sep 30, 2022 | -4.17% |
| Jun 30, 2022 | 3.32% |
| Mar 31, 2022 | 6.45% |
| Dec 31, 2021 | 14.80% |
| Sep 30, 2021 | 15.24% |